Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Feb 1;361(Pt 3):557–566. doi: 10.1042/0264-6021:3610557

Inhibition of the integrases of human immunodeficiency viruses type 1 and type 2 by reverse transcriptases.

Iris Oz 1, Orna Avidan 1, Amnon Hizi 1
PMCID: PMC1222338  PMID: 11802785

Abstract

We present evidence that the integrases (INs) of HIV types 1 and 2 are inhibited in vitro by the reverse transcriptases (RTs) of HIV-1, HIV-2 and murine leukaemia virus. Both 3'-end processing and 3'-end joining (strand transfer) activities of IN were affected by the RTs. Full inhibitions were accomplished with most RT and IN combinations tested at around equimolar RT/IN ratios. The disintegration activity of IN was also inhibited by RTs. Neither DNA synthesis nor the ribonuclease H (RNase H) domain of RT were involved in IN inhibition, since specific DNA polymerase inhibitors did not affect the level of IN inhibition, and the p51 isoform of HIV-1 RT (which lacks the RNase H domain) is as effective in inhibiting IN as the heterodimeric p66/p51 isoform. On the other hand, the catalytic activities of HIV RTs were not affected by the INs, showing that RTs can inhibit IN activities, whereas INs do not inhibit RTs. We postulate that sequences and/or three-dimensional protein structures common to RTs interact with INs and inhibit their activities. We show evidence for this hypothesis and discuss the possible sites of IN involved in this interaction.

Full Text

The Full Text of this article is available as a PDF (332.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiyar A., Hindmarsh P., Skalka A. M., Leis J. Concerted integration of linear retroviral DNA by the avian sarcoma virus integrase in vitro: dependence on both long terminal repeat termini. J Virol. 1996 Jun;70(6):3571–3580. doi: 10.1128/jvi.70.6.3571-3580.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnold E., Das K., Ding J., Yadav P. N., Hsiou Y., Boyer P. L., Hughes S. H. Targeting HIV reverse transcriptase for anti-AIDS drug design: structural and biological considerations for chemotherapeutic strategies. Drug Des Discov. 1996 Apr;13(3-4):29–47. [PubMed] [Google Scholar]
  3. Avidan O., Hizi A. The processivity of DNA synthesis exhibited by drug-resistant variants of human immunodeficiency virus type-1 reverse transcriptase. Nucleic Acids Res. 1998 Apr 1;26(7):1713–1717. doi: 10.1093/nar/26.7.1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barsov E. V., Huber W. E., Marcotrigiano J., Clark P. K., Clark A. D., Arnold E., Hughes S. H. Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions. J Virol. 1996 Jul;70(7):4484–4494. doi: 10.1128/jvi.70.7.4484-4494.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bizub-Bender D., Kulkosky J., Skalka A. M. Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure. AIDS Res Hum Retroviruses. 1994 Sep;10(9):1105–1115. doi: 10.1089/aid.1994.10.1105. [DOI] [PubMed] [Google Scholar]
  6. Boyer P. L., Ding J., Arnold E., Hughes S. H. Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother. 1994 Sep;38(9):1909–1914. doi: 10.1128/aac.38.9.1909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buckheit R. W., Jr, Fliakas-Boltz V., Yeagy-Bargo S., Weislow O., Mayers D. L., Boyer P. L., Hughes S. H., Pan B. C., Chu S. H., Bader J. P. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase. Virology. 1995 Jun 20;210(1):186–193. doi: 10.1006/viro.1995.1330. [DOI] [PubMed] [Google Scholar]
  8. Buckheit R. W., Jr, Hollingshead M. G., Germany-Decker J., White E. L., McMahon J. B., Allen L. B., Ross L. J., Decker W. D., Westbrook L., Shannon W. M. Thiazolobenzimidazole: biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor. Antiviral Res. 1993 Jul;21(3):247–265. doi: 10.1016/0166-3542(93)90031-d. [DOI] [PubMed] [Google Scholar]
  9. Bukrinsky M. I., Sharova N., McDonald T. L., Pushkarskaya T., Tarpley W. G., Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125–6129. doi: 10.1073/pnas.90.13.6125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bushman F. D., Engelman A., Palmer I., Wingfield P., Craigie R. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3428–3432. doi: 10.1073/pnas.90.8.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chow S. A. In vitro assays for activities of retroviral integrase. Methods. 1997 Aug;12(4):306–317. doi: 10.1006/meth.1997.0484. [DOI] [PubMed] [Google Scholar]
  12. Chow S. A., Vincent K. A., Ellison V., Brown P. O. Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus. Science. 1992 Feb 7;255(5045):723–726. doi: 10.1126/science.1738845. [DOI] [PubMed] [Google Scholar]
  13. Davies J. F., 2nd, Almassy R. J., Hostomska Z., Ferre R. A., Hostomsky Z. 2.3 A crystal structure of the catalytic domain of DNA polymerase beta. Cell. 1994 Mar 25;76(6):1123–1133. doi: 10.1016/0092-8674(94)90388-3. [DOI] [PubMed] [Google Scholar]
  14. Farnet C. M., Bushman F. D. HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell. 1997 Feb 21;88(4):483–492. doi: 10.1016/s0092-8674(00)81888-7. [DOI] [PubMed] [Google Scholar]
  15. Fouchier R. A., Malim M. H. Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv Virus Res. 1999;52:275–299. doi: 10.1016/s0065-3527(08)60302-4. [DOI] [PubMed] [Google Scholar]
  16. Gallay P., Swingler S., Song J., Bushman F., Trono D. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 1995 Nov 17;83(4):569–576. doi: 10.1016/0092-8674(95)90097-7. [DOI] [PubMed] [Google Scholar]
  17. Georgiadis M. M., Jessen S. M., Ogata C. M., Telesnitsky A., Goff S. P., Hendrickson W. A. Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure. 1995 Sep 15;3(9):879–892. doi: 10.1016/S0969-2126(01)00223-4. [DOI] [PubMed] [Google Scholar]
  18. Harris D., Engelman A. Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro. J Biol Chem. 2000 Dec 15;275(50):39671–39677. doi: 10.1074/jbc.M002626200. [DOI] [PubMed] [Google Scholar]
  19. Hindmarsh P., Leis J. Retroviral DNA integration. Microbiol Mol Biol Rev. 1999 Dec;63(4):836-43, table of contents. doi: 10.1128/mmbr.63.4.836-843.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hindmarsh P., Ridky T., Reeves R., Andrake M., Skalka A. M., Leis J. HMG protein family members stimulate human immunodeficiency virus type 1 and avian sarcoma virus concerted DNA integration in vitro. J Virol. 1999 Apr;73(4):2994–3003. doi: 10.1128/jvi.73.4.2994-3003.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hizi A., Joklik W. K. The beta subunit of the DNA polymerase of avian sarcoma virus strain B77 is a phosphoprotein. Virology. 1977 May 15;78(2):571–575. doi: 10.1016/0042-6822(77)90132-5. [DOI] [PubMed] [Google Scholar]
  22. Hizi A., McGill C., Hughes S. H. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1218–1222. doi: 10.1073/pnas.85.4.1218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hizi A., Tal R., Hughes S. H. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli. Virology. 1991 Jan;180(1):339–346. doi: 10.1016/0042-6822(91)90038-d. [DOI] [PubMed] [Google Scholar]
  24. Hizi A., Tal R., Shaharabany M., Loya S. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. J Biol Chem. 1991 Apr 5;266(10):6230–6239. [PubMed] [Google Scholar]
  25. Hu S. C., Court D. L., Zweig M., Levin J. G. Murine leukemia virus pol gene products: analysis with antisera generated against reverse transcriptase and endonuclease fusion proteins expressed in Escherichia coli. J Virol. 1986 Oct;60(1):267–274. doi: 10.1128/jvi.60.1.267-274.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ishikawa T., Okui N., Kobayashi N., Sakuma R., Kitamura T., Kitamura Y. Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal region of human immunodeficiency virus type 1 integrase. J Virol. 1999 May;73(5):4475–4480. doi: 10.1128/jvi.73.5.4475-4480.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jacobo-Molina A., Ding J., Nanni R. G., Clark A. D., Jr, Lu X., Tantillo C., Williams R. L., Kamer G., Ferris A. L., Clark P. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6320–6324. doi: 10.1073/pnas.90.13.6320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kalpana G. V., Marmon S., Wang W., Crabtree G. R., Goff S. P. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science. 1994 Dec 23;266(5193):2002–2006. doi: 10.1126/science.7801128. [DOI] [PubMed] [Google Scholar]
  29. Katzman M., Katz R. A., Skalka A. M., Leis J. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J Virol. 1989 Dec;63(12):5319–5327. doi: 10.1128/jvi.63.12.5319-5327.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kulkosky J., Katz R. A., Merkel G., Skalka A. M. Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase. Virology. 1995 Jan 10;206(1):448–456. doi: 10.1016/s0042-6822(95)80060-3. [DOI] [PubMed] [Google Scholar]
  31. Le Grice S. F., Grüninger-Leitch F. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem. 1990 Jan 26;187(2):307–314. doi: 10.1111/j.1432-1033.1990.tb15306.x. [DOI] [PubMed] [Google Scholar]
  32. Lee M. S., Craigie R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1528–1533. doi: 10.1073/pnas.95.4.1528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mazumder A., Cooney D., Agbaria R., Gupta M., Pommier Y. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5771–5775. doi: 10.1073/pnas.91.13.5771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Merluzzi V. J., Hargrave K. D., Labadia M., Grozinger K., Skoog M., Wu J. C., Shih C. K., Eckner K., Hattox S., Adams J. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science. 1990 Dec 7;250(4986):1411–1413. doi: 10.1126/science.1701568. [DOI] [PubMed] [Google Scholar]
  35. Miller M. D., Farnet C. M., Bushman F. D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol. 1997 Jul;71(7):5382–5390. doi: 10.1128/jvi.71.7.5382-5390.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Morozov A., Yung E., Kalpana G. V. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):1120–1125. doi: 10.1073/pnas.95.3.1120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Perach M., Hizi A. Catalytic features of the recombinant reverse transcriptase of bovine leukemia virus expressed in bacteria. Virology. 1999 Jun 20;259(1):176–189. doi: 10.1006/viro.1999.9761. [DOI] [PubMed] [Google Scholar]
  38. Restle T., Müller B., Goody R. S. Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J Biol Chem. 1990 Jun 5;265(16):8986–8988. [PubMed] [Google Scholar]
  39. Restle T., Müller B., Goody R. S. Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J Biol Chem. 1990 Jun 5;265(16):8986–8988. [PubMed] [Google Scholar]
  40. Souquet M., Restle T., Krebs R., Le Grice S. F., Goody R. S., Wöhrl B. M. Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase. Biochemistry. 1998 Sep 1;37(35):12144–12152. doi: 10.1021/bi9731596. [DOI] [PubMed] [Google Scholar]
  41. Tantillo C., Ding J., Jacobo-Molina A., Nanni R. G., Boyer P. L., Hughes S. H., Pauwels R., Andries K., Janssen P. A., Arnold E. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol. 1994 Oct 28;243(3):369–387. doi: 10.1006/jmbi.1994.1665. [DOI] [PubMed] [Google Scholar]
  42. Taube R., Avidan O., Hizi A. The fidelity of misinsertion and mispair extension throughout DNA synthesis exhibited by mutants of the reverse transcriptase of human immunodeficiency virus type 2 resistant to nucleoside analogs. Eur J Biochem. 1997 Nov 15;250(1):106–114. doi: 10.1111/j.1432-1033.1997.00106.x. [DOI] [PubMed] [Google Scholar]
  43. Vink C., Oude Groeneger A. M., Plasterk R. H. Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. Nucleic Acids Res. 1993 Mar 25;21(6):1419–1425. doi: 10.1093/nar/21.6.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wei S. Q., Mizuuchi K., Craigie R. Footprints on the viral DNA ends in moloney murine leukemia virus preintegration complexes reflect a specific association with integrase. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10535–10540. doi: 10.1073/pnas.95.18.10535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wu X., Liu H., Xiao H., Conway J. A., Hehl E., Kalpana G. V., Prasad V., Kappes J. C. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol. 1999 Mar;73(3):2126–2135. doi: 10.1128/jvi.73.3.2126-2135.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. van Gent D. C., Elgersma Y., Bolk M. W., Vink C., Plasterk R. H. DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2. Nucleic Acids Res. 1991 Jul 25;19(14):3821–3827. doi: 10.1093/nar/19.14.3821. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES